LON:ARIX Arix Bioscience (ARIX) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Arix Bioscience Stock (LON:ARIX) 30 days 90 days 365 days Advanced Chart Remove Ads Get Arix Bioscience alerts:Sign Up Key Stats Today's Range N/A50-Day Range 142▼ 14252-Week Range N/AVolume377,046 shsAverage Volume636,934 shsMarket Capitalization£183.73 millionP/E Ratio1,290.91Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewArix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.Read More… Remove Ads Receive ARIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arix Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address ARIX Stock News HeadlinesARIX/USD - Arix US DollarAugust 18, 2024 | investing.comEconomy Minister Jeremy Miles on business support, entrepreneurship and the development bankMay 22, 2024 | msn.comFBI Warns: Wave Of Retiree Cyber Hacks Coming In 2025Try to think back to the fall of 2008… The pandemic accelerated America's descent into a “no-cash society” by several years…April 4, 2025 | Colonial Metals (Ad)Sphere Fluidics Appoints Edward Rayner as Non-Executive DirectorApril 17, 2024 | finance.yahoo.comArix Bioscience PLC (3HY.SG)April 9, 2024 | finance.yahoo.comLife sciences firm ReNeuron which received £13m in Welsh Government support enters administrationMarch 22, 2024 | msn.comAcacia Research: Positive Developments, Discount To Book Value High Despite Recent Price SpikeMarch 18, 2024 | seekingalpha.comAcacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comSee More Headlines ARIX Stock Analysis - Frequently Asked Questions How do I buy shares of Arix Bioscience? Shares of ARIX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Arix Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Arix Bioscience investors own include Eagle Point Credit (ECC), Venture Life Group (VLG), Antero Resources (AR), Bango (BGO), BATM Advanced Communications (BVC), Gresham House (GHE) and Ivanhoe Mines (IVN). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:ARIX CIKN/A Webarixbioscience.com Phone+44-20-72901050FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.11 Trailing P/E Ratio1,290.91 Forward P/E RatioN/A P/E GrowthN/ANet Income£14.96 million Net Margins105.64% Pretax MarginN/A Return on Equity6.41% Return on Assets2.18% Debt Debt-to-Equity Ratio0.01 Current Ratio73.10 Quick Ratio117.67 Sales & Book Value Annual Sales£14.16 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.04 Book ValueGBX 192 per share Price / BookN/AMiscellaneous Outstanding Shares129,390,000Free FloatN/AMarket Cap£183.73 million OptionableNot Optionable Beta1.05 10 Stocks Set to Soar in Spring 2025Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.Get This Free Report This page (LON:ARIX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arix Bioscience plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arix Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.